PTC124-GD-021e-CF: A PHASE 3 EXTENSION STUDY OF ATALUREN (PTC124) IN PATIENTS WITH NONSENSE MUTATION CYSTIC FIBROSIS

Project: Research project

Project Details

StatusFinished
Effective start/end date9/30/15 → 12/31/18

Funding

  • PTC Therapeutics, Inc.